- Home
- JZ vs BOLD Comparison
JZ vs BOLD Comparison
Compare JZ & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- BOLD
- Stock Information
- Founded
- JZ 2011
- BOLD 2018
- Country
- JZ China
- BOLD United States
- Employees
- JZ N/A
- BOLD N/A
- Industry
- JZ Other Consumer Services
- BOLD
- Sector
- JZ Real Estate
- BOLD
- Exchange
- JZ Nasdaq
- BOLD Nasdaq
- Market Cap
- JZ 26.7M
- BOLD 30.3M
- IPO Year
- JZ 2022
- BOLD 2024
- Fundamental
- Price
- JZ $1.65
- BOLD $1.07
- Analyst Decision
- JZ
- BOLD Buy
- Analyst Count
- JZ 0
- BOLD 3
- Target Price
- JZ N/A
- BOLD $4.00
- AVG Volume (30 Days)
- JZ 273.5K
- BOLD 364.4K
- Earning Date
- JZ 01-01-0001
- BOLD 08-11-2025
- Dividend Yield
- JZ N/A
- BOLD N/A
- EPS Growth
- JZ N/A
- BOLD N/A
- EPS
- JZ N/A
- BOLD N/A
- Revenue
- JZ $34,090,704.00
- BOLD N/A
- Revenue This Year
- JZ N/A
- BOLD N/A
- Revenue Next Year
- JZ N/A
- BOLD N/A
- P/E Ratio
- JZ N/A
- BOLD N/A
- Revenue Growth
- JZ N/A
- BOLD N/A
- 52 Week Low
- JZ $1.39
- BOLD $1.00
- 52 Week High
- JZ $14.60
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- JZ 23.24
- BOLD N/A
- Support Level
- JZ $1.39
- BOLD N/A
- Resistance Level
- JZ $2.15
- BOLD N/A
- Average True Range (ATR)
- JZ 0.41
- BOLD 0.00
- MACD
- JZ 0.01
- BOLD 0.00
- Stochastic Oscillator
- JZ 9.60
- BOLD 0.00
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.